Pharmabiz

Brii Bio announces positive end-of-treatment results from phase 2b ENRICH & ENHANCE studies to treat chronic hepatitis B

Brii Bio announces positive end-of-treatment results from phase 2b ENRICH & ENHANCE studies to treat chronic hepatitis B: Durham, North Carolina Monday, July 6, 2026, 18:00 Hrs [I ...
Pharmabiz

SK bioscience selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework

SK bioscience selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework: Incheon, Republic of Korea Monday, July 6, 2026, 16:00 Hrs ...
Pharmabiz

Arima Genomics enters distribution partnership with Active Motif for research-specific Hi-C sequencing kits and services

Arima Genomics enters distribution partnership with Active Motif for research-specific Hi-C sequencing kits and services: Carlsbad, California Monday, July 6, 2026, 17:00 Hrs [IST ...
Pharmabiz

Fischer Medical Ventures highlights strategic partnership as NYB.AI showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures highlights strategic partnership as NYB.AI showcased at NVIDIA GTC Taiwan 2026: Our Bureau, Mumbai Monday, July 6, 2026, 17:25 Hrs [IST] Fischer Medical V ...
Pharmabiz

Liver is increasingly coming under stress from unhealthy dietary habits: Dr Jitendra Singh

Liver is increasingly coming under stress from unhealthy dietary habits: Dr Jitendra Singh: Our Bureau, Mumbai Monday, July 6, 2026, 17:10 Hrs [IST] Union minister of state (indep ...
Pharmabiz

UK MHRA approves Novo Nordisk’s semaglutide to treat MASH in adults with moderate-to-advanced liver fibrosis

UK MHRA approves Novo Nordisk’s semaglutide to treat MASH in adults with moderate-to-advanced liver fibrosis: United Kingdom Monday, July 6, 2026, 13:00 Hrs [IST] The Medicines ...
Pharmabiz

Emcure Pharma arm Marcan to acquire remaining stake in Mantra Pharma

Emcure Pharma arm Marcan to acquire remaining stake in Mantra Pharma: Our Bureau, Mumbai Monday, July 6, 2026, 15:15 Hrs [IST] Emcure Pharmaceuticals announced that Marcan Pharmac ...
Pharmabiz

Immunomic Therapeutics begins patient dosing in phase 1 trial of ITI-9001 to treat Japanese cedar pollen allergy

Immunomic Therapeutics begins patient dosing in phase 1 trial of ITI-9001 to treat Japanese cedar pollen allergy: Rockville, Maryland Monday, July 6, 2026, 11:00 Hrs [IST] Immunom ...
Opinion
PharmabizOpinion

Latest DPCO Amendment signals a new era in pharma packaging to propel supply chain efficiency & traceability

Latest DPCO Amendment signals a new era in pharma packaging to propel supply chain efficiency & traceability: Nandita Vijayasimha, Bengaluru Monday, July 6, 2026, 08:00 Hrs [IST] ...
Pharmabiz

Oliva Therapeutics introduces Amerithroid, a naturally derived T3/T4 thyroid hormone replacement therapy

Oliva Therapeutics introduces Amerithroid, a naturally derived T3/T4 thyroid hormone replacement therapy: Ridgewood, New Jersey Monday, July 6, 2026, 12:00 Hrs [IST] Oliva Therape ...
Pharmabiz

US FDA seeks additional data from Ascelia Pharma’s Orviglance NDA

US FDA seeks additional data from Ascelia Pharma’s Orviglance NDA: Sweden Monday, July 6, 2026, 14:00 Hrs [IST] Ascelia Pharma AB (publ), a biotechnology company focused on impr ...
Pharmabiz

Indian pharma sees recent amendments in DPCO as a constructive regulatory reset

Indian pharma sees recent amendments in DPCO as a constructive regulatory reset: Nandita Vijayasimha, Bengaluru Monday, July 6, 2026, 08:00 Hrs [IST] The recent amendments in Drug ...